Atlas Trials

Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)

Clinical trial NCT04070209 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04070209
Sponsor
Sir Mortimer B. Davis - Jewish General Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Prostate CancerCastration-resistant Prostate Cancer
Start date
2020-10-19
Primary completion
2030-11-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.